Sebia USA

🟣 World Amyloidosis Day 🌍 October 26th 𝐀𝐋 𝐀𝐦𝐲𝐥𝐨𝐢𝐝𝐨𝐬𝐢𝐬 𝐢𝐬 𝐚 𝐫𝐚𝐫𝐞 𝐛𝐮𝐭 𝐬𝐞𝐫𝐢𝐨𝐮𝐬 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐚𝐟𝐟𝐞𝐜𝐭𝐢𝐧𝐠 𝐦𝐚𝐧𝐲 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐰𝐨𝐫𝐥𝐝𝐰𝐢𝐝𝐞. On this day, we highlight the importance of early detection and proper treatment. 🧬 𝐅𝐫𝐞𝐞 𝐋𝐢𝐠𝐡𝐭 𝐂𝐡𝐚𝐢𝐧𝐬 (FLC) play a crucial role in the diagnosis and monitoring of this condition. Using FLC tests allows for early detection of abnormalities, enabling quick and appropriate intervention. Sebia offers global solutions to help diagnosing and monitoring AL Amyloidosis, from FLC assays to 🧪 Serum / Urine Protein Electrophoresis and Immunotyping / Immunofixation. 🎬Watch our 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 𝐫𝐞𝐩𝐥𝐚𝐲 𝐨𝐧 𝐀𝐋 𝐀𝐦𝐲𝐥𝐨𝐢𝐝𝐨𝐬𝐢𝐬 to learn more: https://lnkd.in/eDUT2Mbj Together, let's raise awareness and support research to improve the lives of those affected by AL Amyloidosis. 💪 #WorldALAmyloidosisDay #ALAmyloidosis #Health #FLC #EarlyDiagnosis #Bethelink

📅 Mark Your Calendar for an Insightful Educational Webinar! Join us on November 13, 2024, at 1:00 PM EDT for an in-depth discussion on the use of Capillary Electrophoresis for Hemoglobinopathy and Thalassemia Evaluation with a focus on real-world, case-based approaches. Our expert panel includes: 🩺 Dr. Mark Girton & 🩺 Dr. Matthew C. Wagner Together, they will review complex patient cases and explore the latest advancements in capillary electrophoresis for hemoglobinopathies, including thalassemia diagnosis and management. Whether you’re a seasoned lab professional or looking to deepen your knowledge in this area, this webinar is a must-attend! ✅ Secure your spot today and gain valuable insights into how capillary electrophoresis can improve patient outcomes. 🔗 Register here:https://lnkd.in/eh8M58Fj #Hemoglobinopathy #Thalassemia #CapillaryElectrophoresis #LabScience #Webinar #ContinuingEducation #sebia #sebiausa

Our Team is at the APHL NBS is ready to meet you! We’re thrilled to showcase Sebia’s cutting-edge newborn screening solution, now available for your lab! This is your opportunity to discover how our technology can take your screening process to new heights 🌟 📅 Don’t miss out: Attend one of our special events for an exclusive deep dive into the future of newborn screening with Sebia. 🧬👶 Plus, be sure to stop by our booth to schedule a one-on-one consultation!🔗 Learn more and book your booth appointment here: https://lnkd.in/eXYVvqaz 💥 Bonus! Like, share, and comment on this post for a chance to win our Show Raffle Prize! 🎁 #APHL2024 #NewbornScreening #SebiaSolutions #LabInnovation #HealthcareTransformation

Sebia's #CAPILLARYS 3 DBS system is now available for newborn screening, providing quick, precise, and dependable testing for early identification of #hemoglobin disorders. This cutting-edge technology ensures that babies receive essential care right from the beginning. Curious to know more? Visit Sebia at Booth #202/204 at the #APHL #NewbornScreening Symposium in #Omaha to discover how CAPILLARYS 3 DBS can elevate your screening processes. Learn more here: https://lnkd.in/eRYpB7a5 #sebiausa #sebia #NBS #APHL #newbornscreening

Wil you be at #APHLNBS in Omaha? Meet Sebia's Team of experts at the #APHL Newborn Screening Conference beginning this Sunday October 20th in Omaha, NE! Join us to learn about the CAPILLARYS 3 DBS, Sebia’s innovative solution for #newborn #hemoglobin disorder #screening. Our technology provides accurate, reliable results for early detection and better care. Like, Comment and Share to enter our Show Raffle! Learn more --> https://lnkd.in/e4tZFRDS #APHL2024 #NewbornScreening #NBS#Omaha #sebiausa

We are excited to participate and support the upcoming @theMMRF run/walk fundraiser in Atlanta! The #MMRF Walk/Run events unite patients, caregivers, supporters, and their loved ones to raise awareness and critical funds for finding a cure for Multiple Myeloma. No one fights cancer alone. Together, we will reach the ultimate finish line: a cure. Learn more and help support finding a cure --> https://lnkd.in/e6mKzd2D

Join us at the #APHL Newborn Screening Symposium! 🚨 We’re excited to connect with you and share Sebia’s innovative #newborn screening solution, now available for your lab! Don’t miss out on the opportunity to discover how our technology can enhance your screening process. 🎉 Be sure to attend one of these events for an in-depth look and learn how we’re shaping the future of #newbornscreening. 🧬👶 Monday, October 21, 7:45 – 8:15 AM CST APHL INNOVATE SESSION: Transforming #NBS for #Hb disorders: Introducing the #CAPILLARYS 3 DBS Tuesday, October 22, 12:30 – 1:30 PM CST POSTER #106: Evaluation of the #Sebia CAPILLARYS 3 DBS Instrument for Newborn #Hemoglobinopathy Screening in Arizona Like, Share, and comment to enter our Show #Raffle #Prize! And Don’t forget to schedule your appointment at our booth. We can’t wait to meet you there! https://lnkd.in/eXi8eSQp #NewbornScreening #APHLNBS2024 #Sebia #LaboratoryInnovation #sebiausa

🟣 Didn't get a chance to join our webinar live on 𝗧𝗶𝗺𝗲𝗹𝘆 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗼𝗳 𝗠𝘆𝗲𝗹𝗼𝗺𝗮 𝗶𝗻 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝘄𝗶𝘁𝗵 𝗖𝗼𝗺𝗼𝗿𝗯𝗶𝗱𝗶𝘁𝗶𝗲𝘀 𝗮𝗻𝗱 𝗛𝗲𝗮𝗹𝘁𝗵 𝗗𝗶𝘀𝗽𝗮𝗿𝗶𝘁𝗶𝗲𝘀: 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀? No worries — 🎥 catch the full replay of our webinar at your convenience! ➡️ Watch the on-demand replay: https://lnkd.in/gxw8qe9E Sebia joins the International Myeloma Foundation for hashtag#𝗕𝗹𝗼𝗼𝗱𝗖𝗮𝗻𝗰𝗲𝗿𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀𝗠𝗼𝗻𝘁𝗵. Throughout the month of September, one simple question will be asked: “𝗗𝗼 𝗬𝗼𝘂 𝗞𝗻𝗼𝘄 𝗠𝘆𝗲𝗹𝗼𝗺𝗮?" #KNOWMYELOMA #MyelomaAwareness #CancerAwareness #Healthcare #SupportPatients #MultipleMyeloma #cancer

Celebrating 𝗡𝗲𝘄𝗯𝗼𝗿𝗻 𝗦𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 (𝗡𝗕𝗦) 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵 with the power of Capillary Electrophoresis! This advanced technology is transforming the way we screen for #hemoglobin disorders in newborns. Unmatched Clarity: high-resolution separation, providing clear, accurate identification of hemoglobin variants including S, C, D, E and Bart’s. Precise detection means more reliable results, giving every baby a healthier start! 👉 Discover more about Sebia's solutions for detection of newborn hemoglobin disorders:https://lnkd.in/eQi4CQcu #capillary #Sebia #NBS #NBSAwarenessmonth #Hbdisorders

From September 26 to 30, #Sebia Team will be cycling 450 kilometers from London to Paris with Myeloma UK to raise awareness and funds for Multiple #Myeloma! Myeloma, a blood #cancer affecting plasma cells in the bone marrow, remains incurable despite treatment advances. What we now need is to raise awareness to the general population. This is the noble cause that organizations like Myeloma UK work on tirelessly every day. Please join our Sebia Team in supporting this meaningful cause by sponsoring us during this event and donate on the link below. No contribution is too small. ➡️ To do so, please click here: https://lnkd.in/eZpEhutA 🤝 Together, we can make a significant impact in the fight against myeloma and support those affected by this disease ! Thank you! #multiplemyeloma #bike #donate #bloodcancer